SQZ Biotechnologies Co at Bank of America Healthcare Conference Transcript
Hey, everybody, good afternoon. Welcome back to the Bank of America healthcare conference. I am Tazeen Ahmad; I'm one of the SMID biotech analysts here. It's my pleasure to have our next presenting company SQZ Biotechnologies. Sitting next to me right now is Armon Sharei, who's Founder and CEO of SQZ. This is one of our recent IPOs, so there might be a few people in the room who may not be as familiar with the company. So for that reason, I think maybe, Armon, it would be a good idea if you could just give us a two-minute overview of the company and its platform, and then we can go into some more specific questions after that.
Sure. Sounds good. So we weren't very creative with our naming. The company is built around squeezing cells. So essentially, during my PhD, we discovered that if you squish cells at high speeds, you can end up disrupting the membrane temporarily, such that anything that's outside the cells will diffuse into them and then the cells are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |